Cargando…

Population structure of drug-resistant Mycobacterium tuberculosis in Central Asia

BACKGROUND: Drug-resistant tuberculosis (TB) is a major public health concern threathing the success of TB control efforts, and this is particularily problematic in Central Asia. Here, we present the first analysis of the population structure of Mycobacterium tuberculosis complex isolates in the Cen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Engström, Anna, Antonenka, Uladzimir, Kadyrov, Abdylat, Kalmambetova, Gulmira, Kranzer, Katharina, Merker, Matthias, Kabirov, Olim, Parpieva, Nargiza, Rajabov, Asliddin, Sahalchyk, Evgeni, Sayfudtinov, Zayniddin, Niemann, Stefan, Hoffmann, Harald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819405/ https://www.ncbi.nlm.nih.gov/pubmed/31664926 http://dx.doi.org/10.1186/s12879-019-4480-7

Ejemplares similares

QuantiFERON-TB Gold plus testing for the detection of LTBI among health care workers in major TB hospitals of the Northern Kyrgyz Republic
por: Corbett, Caroline, et al.
Publicado: (2022)

Implementing contact tracing for tuberculosis in Kyrgyz Republic and risk factors for positivity using QuantiFERON-TB Gold plus
por: Corbett, Caroline, et al.
Publicado: (2020)

Implementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high MDR-TB burden country
por: Vogel, Monica, et al.
Publicado: (2021)

Comparison of Xpert MTB/RIF with ProbeTec ET DTB and COBAS TaqMan MTB for direct detection of M. tuberculosis complex in respiratory specimens
por: Antonenka, Uladzimir, et al.
Publicado: (2013)

Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–2018
por: Sayfutdinov, Zayniddin, et al.
Publicado: (2021)

Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis
por: Achar, Jay, et al.
Publicado: (2017)

A Diagnostic Algorithm To Investigate Pyrazinamide and Ethambutol Resistance in Rifampin-Resistant Mycobacterium tuberculosis Isolates in a Low-Incidence Setting
por: Andres, Söenke, et al.
Publicado: (2019)

Quality of Electronic TB Register Data Compared with Paper-Based Records in the Kyrgyz Republic
por: Shauer, Daniil, et al.
Publicado: (2023)

Strengthening the Operational Research Capacity of National Tuberculosis Control Programs: Necessity or Luxury?
por: Zachariah, Rony, et al.
Publicado: (2023)

Hospitalizations and Treatment Outcomes in Patients with Urogenital Tuberculosis in Tashkent, Uzbekistan, 2016–2018
por: Ismatov, Bakhtiyor, et al.
Publicado: (2021)

Universal Access to Xpert MTB/RIF Testing for Diagnosis of Tuberculosis in Uzbekistan: How Well Are We Doing?
por: Turaev, Laziz, et al.
Publicado: (2021)

Characteristics and Treatment Outcomes of Patients with Tuberculosis Receiving Adjunctive Surgery in Uzbekistan
por: Riskiyev, Anvar, et al.
Publicado: (2021)

Detection of Mycobacterium tuberculosis Complex Using the Xpert MTB/RIF Ultra Assay on the Stool of Pediatric Patients in Dushanbe, Tajikistan
por: Rekart, Michael L., et al.
Publicado: (2023)

Yersinia enterocolitica palearctica serobiotype O:3/4 - a successful group of emerging zoonotic pathogens
por: Batzilla, Julia, et al.
Publicado: (2011)

Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan
por: Horter, Shona, et al.
Publicado: (2020)

Adverse Drug Reactions among Children with Tuberculosis in Tashkent, Uzbekistan, 2019
por: Abdusalomova, Makhliyo, et al.
Publicado: (2021)

Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan
por: Horter, Shona, et al.
Publicado: (2020)

Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis
por: Trubnikov, Aleksandr, et al.
Publicado: (2021)

Risk Factors for Unfavorable Treatment Outcomes among the Human Immunodeficiency Virus-Associated Tuberculosis Population in Tashkent City, Uzbekistan: 2013–2017
por: Massavirov, Sherali, et al.
Publicado: (2021)

Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018
por: Safaev, Khasan, et al.
Publicado: (2021)

Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan
por: Horter, Shona, et al.
Publicado: (2016)

Treatment Compliance of Multidrug Resistant Tuberculosis in Uzbekistan: Does Practice Follow Policy?
por: Usmanova, Ruzilya, et al.
Publicado: (2021)

Compensatory evolution drives multidrug-resistant tuberculosis in Central Asia
por: Merker, Matthias, et al.
Publicado: (2018)

A Comparison of Pain Scores in Dysmenorrheic Patients With or Without Dyspeptic Symptoms
por: Sezgin, Yılmaz, et al.
Publicado: (2021)

Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?
por: Yuldashev, Sharofiddin, et al.
Publicado: (2021)

Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
por: Skrahina, Alena, et al.
Publicado: (2012)

Diagnostic Procedures, Diagnoses, and Treatment Outcomes of Patients with Presumptive Tuberculosis Pleural Effusion in Uzbekistan
por: Abdugapparov, Fazlkhan, et al.
Publicado: (2021)

Evaluation of the Roche cobas MTB and MTB-RIF/INH Assays in Samples from Germany and Sierra Leone
por: Nadarajan, Darshaalini, et al.
Publicado: (2021)

Tuberculous Lymphadenitis in Ethiopia Predominantly Caused by Strains Belonging to the Delhi/CAS Lineage and Newly Identified Ethiopian Clades of the Mycobacterium tuberculosis Complex
por: Biadglegne, Fantahun, et al.
Publicado: (2015)

Mycobacterium tuberculosis Complex Lineage 3 as Causative Agent of Pulmonary Tuberculosis, Eastern Sudan
por: Shuaib, Yassir A., et al.
Publicado: (2020)

Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan
por: Trauer, James M., et al.
Publicado: (2016)

Operational Research to Inform Programmatic Approaches to the Management of Tuberculosis in Uzbekistan
por: Gadoev, Jamshid, et al.
Publicado: (2021)

Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen
por: Achar, Jay, et al.
Publicado: (2015)

Incidence Rate and Risk Factors for Tuberculosis among People Living with HIV: A 2015–2017 Cohort from Tashkent, Uzbekistan
por: Sadirova, Dilbar, et al.
Publicado: (2021)

Delineating Mycobacterium abscessus population structure and transmission employing high-resolution core genome multilocus sequence typing
por: Diricks, Margo, et al.
Publicado: (2022)

A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study
por: Walker, Timothy M, et al.
Publicado: (2018)

Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in Northwest Ethiopia: new phylogenetic lineages found in Northwest Ethiopia
por: Tessema, Belay, et al.
Publicado: (2013)

Rapid microarray-based assay for detection of pyrazinamide resistant Mycobacterium tuberculosis
por: Havlicek, Juliane, et al.
Publicado: (2019)

Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan
por: Gadoev, Jamshid, et al.
Publicado: (2017)

Microevolution of Mycobacterium tuberculosis Subpopulations and Heteroresistance in a Patient Receiving 27 Years of Tuberculosis Treatment in Germany
por: Sonnenkalb, Lindsay, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7vos61c6oln8upe4a72u2hqd93